Friday, May 20, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Do androgens play a role in COVID-19 severity?

by Medical Finance
in Coronavirus
Study: Androgen receptor polyQ alleles and COVID-19 severity in men: a replication study. Image Credit: kostasgr / Shutterstock.com
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

As of April 5, 2022, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease 2019 (COVID-19), has infected over 493 million and caused over 6.15 million deaths worldwide.

Study: Androgen receptor polyQ alleles and COVID-19 severity in men: a replication study. Image Credit: kostasgr / Shutterstock.com

Study: Androgen receptor polyQ alleles and COVID-19 severity in men: a replication study. Image Credit: kostasgr / Shutterstock.com

Sex-related differences in COVID-19

Several studies have suggested a sex-related difference in the severity of COVID-19 that contributed to less favorable outcomes in men. However, age, lifestyle factors, comorbidities, and infection rates are not able to explain these sex-related differences in disease outcomes.

Thus, some researchers have proposed that genetics likely contributes to these sex-based differences, as many X-linked genes are known to be involved in the immune response. For example, several recent studies have indicated an association between the polyQ polymorphism within exon 1 in the androgen receptor (AR) Xq12 gene and COVID-19 severity.

This genetic mutation consists of a polymorphic CAG repeat segment that is located at the N-terminal transactivation domain. The presence of 23 or more CAG repeats has been associated with more severe COVID-19 outcomes in an initial cohort of Italian men and women, as well as an independent cohort of Spanish males.

The response to androgen hormones is mediated by AR which, upon binding to androgen, moves to the nucleus and regulates the expression of the androgen-responsive genes. Previous studies have indicated that lower testosterone concentrations are associated with higher severity and mortality in males with COVID-19.

The expression of the transmembrane serine protease 2 (TMPRSS2), which is a protease that cleaves the SARS-CoV-2 spike protein, is regulated by the androgen response. Furthermore, the transactivational activity of AR has been reported to be regulated by the polyQ polymorphism.

A new study published on the preprint server medRxiv* assesses the association between the AR polyQ polymorphism with COVID-19 severity using a large cohort of 1,136 COVID-19 male patients.

About the study

The current study included 1,136 male patients who were recruited from four hospitals in Spain and were infected by SARS-CoV-2, as indicated by positive reverse-transcription polymerase chain reaction (RT-PCR). All study participants were enrolled retrospectively and prospectively into the study from March 2020 to November 2020 and were followed up until February 2021.

Clinical information which included demographic data, COVID-19 symptoms, related complications from COVID-19, comorbidities, laboratory findings, intensive care unit (ICU) admission, treatments, and outcomes were collected from electronic medical records. The patients were then stratified using three criteria including asymptomatic, oligosymptomatic, or patients with mild symptoms who did not require hospitalization, hospitalized patients who did not require invasive or non-invasive mechanical ventilation, or patients with severe SAR-CoV-2 infection who were admitted to hospital and required intubation, non-invasive ventilation, or high-flow nasal cannula.

Genomic DNA isolated from collected blood samples was used to determine the number of CAG repeats (polyQ polymorphisms) at the AR. Accordingly, patients were classified into short (<23 repeats) or long (≥23 repeats) allele carriers.

The ancestry of each patient was determined with the help of principal component analysis (PCA). This allowed for the patients’ ethnicity to be classified as European, admixed American, African, or East Asian.

Study findings

The average age of the patients was about 61 years, a majority of whom were of European origin. The two frequent comorbidities reported among the patients were hypertension and obesity. A total of 15.5% of patients were oligosymptomatic, 21.3% experienced severe COVID-19, and 63.2% required hospitalization without any respiratory support.

The mean number of polyQ CAG repeats was 22. The distribution of both short and long alleles did not show any significant difference between severity classes.

Moreover, the distribution of longer polyQ alleles was similar among more severe patients and milder cases. No significant difference in the distribution of the longer allele was observed with age. Furthermore, patients of European ancestry were similar to the entire study population.

The researchers also reported that factors such as age, ethnicity, obesity, and enrollment centers were associated with COVID-19 severity; however, longer polyQ alleles were not associated.

Taken together, the current study determined that the value of the polyQ polymorphism in the AR gene did not serve as a severity biomarker of COVID-19. Further research is required to understand the association between androgens and COVID-19 severity.

*Important notice

medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Heterologous immunization with inactivated vaccine followed by mRNA booster elicits strong humoral and cellular immune responses against the SARS-CoV-2 Omicron variant. Image Credit: Teeradej/Shutterstock

Study finds heterologous vaccine booster evokes robust immunity to SARS-CoV-2 Omicron variant

by Medical Finance
May 20, 2022
0

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that emerged in the last month of 2019 has undergone several...

Study: Egg-derived anti-SARS-CoV-2 immunoglobulin Y (IgY) with broad variant activity as intranasal prophylaxis against COVID-19: preclinical studies and randomized controlled phase 1 clinical trial. Image Credit: NIAID

An egg-derived SARS-CoV-2 vaccine and treatment for COVID-19 disease

by Medical Finance
May 20, 2022
0

Coronavirus disease 2019 (COVID-19), caused by the rapid outbreak of severe acute respiratory disease coronavirus-2 (SARS-CoV-2), has claimed more than...

Economic Impact of COVID-19

How has COVID-19 Impacted our Economy?

by Medical Finance
May 20, 2022
0

In this interview, News-Medical talks to Professor Adam Rose and his research team about how direct behavioral responses to COVID-19...

Study: Transmission of Omicron (B.1.1.529) - SARS-CoV-2 Variant of Concern in a designated quarantine hotel for travelers: a challenge of elimination strategy of COVID-19. Image Credit: Kitch Bain / Shutterstock

Transmission of Omicron in a quarantine hotel between two vaccinated individuals across a corridor

by Medical Finance
May 20, 2022
0

Since the beginning of the ongoing coronavirus disease 2019 (COVID-19) pandemic, the causative agent, severe acute respiratory syndrome coronavirus 2...

Study: Covariant Fitness Clusters Reveal Structural Evolution of SARS-CoV-2 Polymerase Across the Human Population. Image Credit: Naeblys/Shutterstock

Analyzing the evolution of SARS-CoV-2 RNA polymerase in humans

by Medical Finance
May 20, 2022
0

A recent work posted by researchers to the bioRxiv* preprint server investigated the evolutionary aspects of severe acute respiratory syndrome...

Study: A method for variant agnostic detection of SARS-CoV-2, rapid monitoring of circulating variants, detection of mutations of biological significance, and early detection of emergent variants such as Omicron. Image Credit: Lightspring/Shutterstock

New method for monitoring circulating SARS-CoV-2 variants and detecting new ones

by Medical Finance
May 20, 2022
0

After more than two years of the coronavirus disease (COVID-19) pandemic, there is still a constant threat of evolving strains...

Next Post
Single-cycle kinetics of Influenza A protein binding to immobilized Influenza A Antibodies on Alto. Influenza A protein analyte was titrated from 1.2 nM to 100 nM. The black curve is the Langmuir 1:1 binding fit model analyzed in the Nicoya Analysis Software.

Characterizing the kinetics and epitopes of influenza antiviral targets

Expressing recombinant proteins with a baculovirus-insect cell system

Expressing recombinant proteins with a baculovirus-insect cell system

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • 163926142 620x480
    Yale research sheds light on the lifespan and myriad functions of messenger RNAs
  • Study: Assessment of Mutations on RBD in the Spike Protein of SARS-CoV-2 Alpha, Delta and Omicron Variants. Image Credit: Akarat Jarernthanawut/Shutterstock
    Molecular dynamic simulations unveil conformational dynamics of SARS-CoV-2 spike protein RBD and ACE2 receptor
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply